GLN Requirements and Compliance for Drug Supply Chain

This document is a guide that outlines the requirements for obtaining and using a Global Location Number (GLN) in compliance with the Drug Supply Chain Security Act (DSCSA), effective November 27, 2023. It explains the significance of the GLN, which is essential for tracking products and ensuring visibility throughout the supply chain. The guide details that all customers, regardless of size or class of trade, must have a GLN to transact business with AmerisourceBergen or any distributor. It also describes the process for obtaining a GLN, including the proactive measures AmerisourceBergen is taking to assist customers who do not have one. Additionally, the document provides contact information for customers needing assistance with GLN-related inquiries and emphasizes the importance of compliance with federal regulations to avoid disruptions in business transactions. Overall, the guide serves as a comprehensive resource for understanding GLN requirements and their implications for supply chain operations.